← All stories
Markets
Conavi Medical Reports Fiscal Third Quarter 2026 Results and Operational Highlights
Net loss for Fiscal Q3 2026 was $6.3 million (Fiscal Q3 2025 – $3.6 million) reflecting continued investment in research and development activities of $4.4 million (Fiscal Q3 2025 – $3.2 million) Ended Fiscal Q3 2026 with $0.9M in cash and…
Covered by 1 outlet
All coverage · 1 article